This spring one group of Americans had extra reason to be rattled by the pandemic: women with breast cancer. But as they wondered how they’d manage in the face of overflowing hospitals and drastic new social-distancing rules, oncologists, researchers, and other experts leaped into action, swiftly devising new plans and protocols that respected both cancer and Covid-19. Better yet, the innovations didn’t just help women during the chaotic first wave—they will continue to inform research and treatment through the pandemic and beyond.

Read more here

C. Ola Landgren, MD, PhD, chief of Myeloma Service and hematologic oncologist at Memorial Sloan Kettering Cancer Center, discusses what is next for chimeric antigen receptor (CAR) T-cell therapy in the multiple myeloma landscape.

Read more here

Persistent radiation-induced alopecia in patients with primary central nervous system (CNS) tumors or head and neck sarcomas is dose-dependent and has distinctive clinical and trichoscopic features, according to our findings published recently in JAMA Dermatology. This distressing adverse effect of cancer therapy may benefit from treatment.

Read more here